PRESCRIBING ATTITUDES OF DIFFERENT PHYSICIAN GROUPS REGARDING FLUOXETINE

被引:5
作者
LEVIN, GM
DEVANE, CL
机构
[1] UNIV FLORIDA,DEPT PHARM PRACTICE,GAINESVILLE,FL
[2] UNIV FLORIDA,DEPT PSYCHIAT,GAINESVILLE,FL 32611
关键词
D O I
10.1177/106002809302701204
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: TO determine the attitudes and prescribing patterns of family medicine and psychiatric physicians regarding fluoxetine. DESIGN: A three-part questionnaire was distributed to the Departments of Family Medicine and Psychiatry. The survey included topics associated with fluoxetine use that have received broad professional attention, such as drug-induced suicidal and aggressive behavior. SETTING: The Family Practice Medical Group and the Department of Psychiatry at the University of Florida. PARTICIPANTS: Mailing lists from both above departments were used to distribute surveys to residents, fellows, and attending/faculty members of each department. Eighty-seven surveys were mailed. MAIN OUTCOME MEASURES: Survey questions were divided into three sections to help determine current attitudes of prescribing fluoxetine: eight short cases, 16 statements, and demographic data. RESULTS: The return rate was 69 percent following a mailing and a hand-delivered copy. Responses were dichotomized to agree or disagree and were analyzed by Fisher's exact test. Psychiatrists were much more likely than family practitioners to prescribe fluoxetine for obsessive-compulsive disorder (OCD), and more likely to prescribe for a patient with a history of substance abuse or seizure disorder. Psychiatrists were more aware of safety issues; however, drug-interaction knowledge was weak in both groups. CONCLUSIONS: Family practitioners, being the most predominant of medical specialists, appeared equally comfortable with prescribing fluoxetine in most circumstances compared with psychiatrists. However, there is a need for pharmacists to provide up-to-date drug information on fluoxetine to all healthcare professionals.
引用
收藏
页码:1443 / 1447
页数:5
相关论文
共 21 条
  • [1] Jenike M.A., Buttolph L., Baer L., Ricciardi J., Holland A., Open trial of fluoxetine in obsessive-compulsive disorder, Am J Psychiatry, 146, pp. 909-911, (1989)
  • [2] Borys D.J., Setzer S.C., Ling L.J., Reisdorf J.J., Day L.C., Krenzelok E.P., The effects of fluoxetine in overdose, Clin Toxicol, 28, pp. 331-340, (1990)
  • [3] Spiller H.A., Morse S., Muir C., Fluoxetine ingestion: A one year retrospective study, Vet Hum Toxicol, 32, pp. 153-155, (1990)
  • [4] Kincaid R.L., McMullin M.M., Crookham S.B., Rieders F., Report of a fluoxetine fatality, J Anal Toxicol, 14, pp. 327-329, (1990)
  • [5] Ciraulo D.A., Shader R.I., Fluoxetine drug-drug interactions II, J Clin Psychopharmacol, 10, pp. 213-217, (1990)
  • [6] Aranow R.B., Hudson J.I., Pope H.G., Grady T.A., Laage T.A., Bell I.R., Et al., Elevated antidepressant plasma levels after addition of fluoxetine, Am J Psychiatry, 146, pp. 911-913, (1989)
  • [7] Teicher M.H., Glod C., Cole J.O., Emergence of intense suicidal preoccupation during fluoxetine treatment, Am J Psychiatry, 147, pp. 207-210, (1990)
  • [8] Fava M., Rosenbaum J.F., Suicidality and fluoxetine: Is there a relationship?, J Clin Psychiatry, 52, pp. 108-111, (1991)
  • [9] King R.A., Riddle M.A., Chappell P.B., Hardin M.T., Anderson G.M., Lombroso P., Et al., Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment, J Am Acad Child Adolesc Psychiatry, 30, pp. 179-186, (1991)
  • [10] Fava M., Rosenbaum J.F., McCarthy M., Pava J., Steingard R., Bless E., Anger attacks in depressed outpatients and their response to fluoxetine, Psychopharmacol Bull, 27, pp. 275-279, (1991)